Works matching DE "ADALIMUMAB"

Results: 2255

Isolated Urticarial Rash in the Clinical Spectrum of HA20.

Published in:

Journal of Rheumatology, 2025, v. 52, n. 5, p. 520, doi. 10.3899/jrheum.2024-1134

By:

Mastrolia, Maria Vincenza;
Duan, Lucy;
Pennal, Alexandra;
Laxer, Ronald M.;
Dissanayake, Dilan

Publication type:

Article

Comparative evaluation of efficacy and tolerability of apremilast and methotrexate in patients of moderate-to-severe palmoplantar psoriasis: A randomized, parallel, open-label clinical trial.

Published in:

Indian Journal of Pharmacology, 2023, v. 55, n. 6, p. 356, doi. 10.4103/ijp.ijp_190_23

By:

Wagh, Mitali;
Mukhi, Jayesh;
Sontakke, Smita;
Dhok, Amit;
Turankar, Avinash;
Kalikar, Mrunalini

Publication type:

Article

The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial.

Published in:

Indian Journal of Pharmacology, 2020, v. 52, n. 1, p. 16, doi. 10.4103/ijp.IJP_88_19

By:

Abidi, Afroz;
Rizvi, Dilshad;
Saxena, Kshitij;
Chaudhary, Savita;
Ahmad, Ali

Publication type:

Article

Factor XI deficiency diagnosed following use of adalimumab.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 5, p. 553, doi. 10.4103/0253-7613.140596

By:

Cetin, Guven;
Karatoprak, Cumali;
Kiskac, Muharrem;
Zorlu, Mehmet;
Rezvani, Aylin;
Ali Cikrikcioglu, Mehmet

Publication type:

Article

Alopecia Areata during Treatment of Psoriasis with Adalimumab and Leflunomide: A Case and Review of the Literature.

Published in:

Skin Pharmacology & Physiology, 2012, v. 25, n. 2, p. 107, doi. 10.1159/000335264

By:

Navarro, R.;
Daudén, E.;
Gallo, E.;
Santiago Sánchez-Mateos, D.;
García-Diez, A.

Publication type:

Article

Structure-based development and optimization of therapy antibody drugs against TNFα.

Published in:

Amino Acids, 2015, v. 47, n. 6, p. 1259, doi. 10.1007/s00726-015-1954-9

By:

Fu, Wenyan;
Wang, Xiaoze;
Yang, Weili;
Takeda, Hiroaki;
Hu, Shi;
Lou, Zhiyong;
Zhao, Jian;
Bethune, Augus;
Guo, Yajun

Publication type:

Article

Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.

Published in:

Digestive Diseases, 2024, v. 42, n. 4, p. 325, doi. 10.1159/000535647

By:

Sokic-Milutinovic, Aleksandra;
Milosavljevic, Tomica

Publication type:

Article

Comparative Analysis of the 3-Year Persistence Rate with Second-Line Vedolizumab and Tumor Necrosis Factor-α Inhibitors in Patients with Inflammatory Bowel Disease Followed in Gastroenterology Practices in Germany.

Published in:

Digestive Diseases, 2020, v. 38, n. 6, p. 466, doi. 10.1159/000506121

By:

Helwig, Ulf;
Braegger, Fiona;
Kostev, Karel;
Schmidt, Carsten

Publication type:

Article

Front & Back Matter.

Published in:: Digestive Diseases, 2018, v. 37, n. 1, p. N.PAG
Publication type:: Article

Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan.

Published in:

Digestive Diseases, 2019, v. 37, n. 2, p. 123, doi. 10.1159/000493462

By:

Kawai, Yumi;
Tsuchiya, Tsuyoshi;
Aoki, Shigeru

Publication type:

Article

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.

Published in:

Digestive Diseases, 2018, v. 37, n. 1, p. 11, doi. 10.1159/000493121

By:

Sugimoto, Ken;
Ikeya, Kentaro;
Kato, Masaichi;
Matsuura, Ai;
Watanabe, Fumitoshi;
Takano, Ryosuke;
Tamura, Satoshi;
Tani, Shinya;
Osawa, Satoshi;
Hanai, Hiroyuki

Publication type:

Article

How Safe Are Biological Agents in Pediatric Rheumatology?

Published in:

Turkish Archives of Pediatrics, 2024, v. 59, n. 2, p. 185, doi. 10.5152/TurkArchPediatr.2024.23221

By:

Sunar Yayla, Emine Nur;
Yıldız, Çisem;
Şenol, Pelin Esmeray;
Karaçayır, Nihal;
Yıldırım, Deniz Gezgin;
Bakkaloğlu, Sevcan A.

Publication type:

Article

An Overview of Pediatric Uveitis.

Published in:

Turkish Archives of Pediatrics, 2023, v. 58, n. 4, p. 363, doi. 10.5152/TurkArchPediatr.2023.23086

By:

Tuğal-Tutkun, İlknur

Publication type:

Article

Analysis of access to treatment of patients with psoriatic arthritis within nationally founded treatment program B.35 "Treatment of active Psoriatic arthritis (PsA) (ICD-10 L 40.5, M 07.1, M 07.2, M 07.3)" in 2016-2021.

Published in:

Forum Dermatologicum, 2023, v. 9, n. 1, p. 1, doi. 10.5603/FD.a2023.0001

By:

Noweta, Marcin;
Narbutt, Joanna;
Lesiak, Aleksandra

Publication type:

Article

Analiza dostępu do leczenia pacjentów z łuszczycą w ramach programu lekowego B.47 „Leczenie umiarkowanej i ciężkiej postaci łuszczycy plackowatej (ICD-10 L 40.0)” w latach 2016–2021.

Published in:

Forum Dermatologicum, 2022, v. 8, n. 3, p. 111, doi. 10.5603/FD.a2022.0021

By:

Noweta, Marcin;
Narbutt, Joanna;
Lesiak, Aleksandra

Publication type:

Article

Combined inhibition of tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF) for the treatment of macular edema of various etiologies: a short-term pilot study.

Published in:

Eye (0950-222X), 2013, v. 27, n. 4, p. 569, doi. 10.1038/eye.2012.301

By:

Arevalo, J F;
Serrano, M A;
Wu, L

Publication type:

Article

Adalimumab specifically induces CD3+ CD4+ CD25high Foxp3+ CD127− T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

Published in:

Eye (0950-222X), 2012, v. 26, n. 3, p. 468, doi. 10.1038/eye.2011.320

By:

Calleja, S;
Cordero-Coma, M;
Rodriguez, E;
Llorente, M;
Franco, M;
Ruiz de Morales, J G

Publication type:

Article

Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study.

Published in:

Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rkz015

By:

Cannon, Grant W;
Erickson, Alan R;
Teng, Chia-Chen;
Huynh, Tina;
Austin, Sharon;
Wade, Sally W;
Stolshek, Bradley S;
Collier, David H;
Mutebi, Alex;
Sauer, Brian C

Publication type:

Article

A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN'S DISEASE AND LUMINAL CROHN'S DISEASE: A COMPARATIVE COHORT STUDY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 166, doi. 10.1093/jcag/gwab002.157

By:

Fung, M;
Siw, K Chin Koon;
McCurdy, J D

Publication type:

Article

A157 REAL-WORLD TIGHT OBJECTIVE MONITORING WITH ADALIMUMAB LEADS TO EARLIER DOSE OPTIMIZATION AND HIGHER CLINICAL REMISSION RATES AT 12 MONTHS.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 163, doi. 10.1093/jcag/gwab002.155

By:

Xiao, Y;
Khoury, A Al;
Golovics, P;
Kohen, R;
Afif, W;
Wild, G;
Friedman, G;
Galiatsatos, P;
Hilzenrat, N;
Szilagyi, A;
Wyse, J;
Cohen, A;
Bitton, A;
Bessissow, T;
Lakatos, P L

Publication type:

Article

A156 SERUM TUMOUR NECROSIS FACTOR-α ANTAGONIST DRUG CONCENTRATIONS IN PATIENTS WITH PYODERMA GANGRENOSUM ASSOSCIATED WITH INFLAMMATORY BOWEL DISEASE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 162, doi. 10.1093/jcag/gwab002.154

By:

Mikail, M;
Wilson, A

Publication type:

Article

Favorable efficacy of adalimumab treatment in experimental acute pancreatitis model.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 6, p. 1821, doi. 10.55730/1300-0144.5528

By:

ÇAKIR GÜNEY, Başak;
TANOĞLU, Alpaslan;
YENİÇERİ, Murat;
ÇIRAK, Zafer;
SADE, Ayşe Gökçen;
TAŞTAN, Yeşim ÖNAL;
SERİNDAĞ, Zeliha;
KAPLAN, Mustafa

Publication type:

Article

Survival of biological therapeutics in psoriasis: retrospective analysis of 3-years data in a Turkish registry, PSORTAKSIS.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 1, p. 58, doi. 10.3906/sag-2104-339

By:

ÖZYURT, Kemal;
ZARARSIZ, Gökmen;
ERTAŞ, Ragıp;
CEPHE, Ahu;
KUTLU, Ömer;
ELMAS, Ömer Faruk;
AKKUŞ, Muhammed Reşat;
KUTLU, Fatma Nur;
ATASOY, Mustafa

Publication type:

Article

Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury.

Published in:

Turkish Journal of Medical Sciences, 2021, v. 51, n. 5, p. 2741, doi. 10.3906/sag-2010-303

By:

SARIOĞLU, Nurhan;
SUNAY, Fatma Bahar;
YAY, Arzu;
KORKUT, Oğuzhan;
EREL, Fuat;
HİŞMİOĞULLARI, Adnan Adil;
KÖSE, Mehmet;
YALÇIN, Betül

Publication type:

Article

Prospective clinical study to assess the efficacy of the topical use of mineral water from the spring of Las Salinas on plaque psoriasis.

Published in:

Journal of Cosmetic Dermatology, 2023, v. 22, n. 7, p. 2133, doi. 10.1111/jocd.15686

By:

Sánchez, Virginia;
Gallo, Elena;
Camacho, Diana;
García, Aroa;
Feltes, Federico;
Pumar, Consuelo;
Martin, Mar

Publication type:

Article

Case of chilblain lupus triggered by adalimumab therapy in a patient with psoriasis.

Published in:

2022

By:

Semiz, Yavuz;
Yıldırım Bay, Esra;
Oğuz Topal, İlteriş;
Yalçın, Özben

Publication type:

Case Study

A PHARMACEUTICAL GUIDE TO ADALIMUMAB BIOSIMILARS.

Published in:

Farmacia, 2022, v. 70, n. 3, p. 379, doi. 10.31925/farmacia.2022.3.1

By:

ALMAAYTAH, AMMAR

Publication type:

Article

Complete primary treatment failure of adalimumab in a patient with photoaggravated psoriasis.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2015, v. 31, n. 2, p. 104, doi. 10.1111/phpp.12132

By:

Kulapatrapa, Chanika;
Rünger, Thomas M.

Publication type:

Article

Effect of low-calorie diet on psoriasis severity index, triglycerides, liver enzymes, and quality of life in psoriatic patients with non-alcoholic fatty liver disease.

Published in:

Rheumatology / Reumatologia, 2023, v. 61, n. 2, p. 116, doi. 10.5114/reum/162995

By:

Ismail, Ali Mohamed Ali;
Saad, Ahmad Elsayed;
Draz, Ramy Salama

Publication type:

Article

Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.

Published in:

2016

By:

Bosnić, Dubravka;
Žarković, Branimir;
Barešić, Marko;
Zarkovic, Maja;
Anić, Branimir

Publication type:

Case Study

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn's disease.

Published in:

Gastroenterology Review / Przegląd Gastroenterologiczny, 2017, v. 12, n. 1, p. 44, doi. 10.5114/pg.2016.64746

By:

Szymanska, Edyta;
Dadalski, Maciej;
Grajkowska, Wieslawa;
Szymanska, Sylwia;
Pronicki, Maciej;
Kierkus, Jaroslaw

Publication type:

Article

Not only anti-inflammation, etanercept abrogates collagen-induced arthritis by inhibiting dendritic cell migration and maturation.

Published in:

Central European Journal of Immunology, 2019, v. 44, n. 3, p. 237, doi. 10.5114/ceji.2019.89595

By:

XUECHAN HUANG;
YI HE;
JIAOCHAN HAN;
JIAN ZHUANG;
JUAN HE;
ERWEI SUN

Publication type:

Article

Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease.

Published in:

Pharmacy, 2022, v. 10, n. 4, p. 87, doi. 10.3390/pharmacy10040087

By:

Liu, Yifei;
Söderberg, Joakim;
Chao, Jingdong

Publication type:

Article

Reversed-Phase Analyses of Monoclonal Antibodies Using High Temperatures.

Published in:: LC-GC Europe, 2019, v. 32, n. 3, p. 170
Publication type:: Article

Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real-world finding.

Published in:

Immunity, Inflammation & Disease, 2024, v. 12, n. 2, p. 1, doi. 10.1002/iid3.1166

By:

Zhe Yu;
Ling Gao;
Yinshan Zang;
Lu Cheng;
Wenjia Gao;
Yan Xu

Publication type:

Article

A study of the efficacy and safety of plaque psoriasis treatment by TNF‐α and IL‐17A inhibitor biologics in patients who received the inactivated SARS‐CoV‐2 vaccine.

Published in:

Immunity, Inflammation & Disease, 2023, v. 11, n. 7, p. 1, doi. 10.1002/iid3.938

By:

Ye, Shuhong;
Sun, Hong;
Xu, Zining;
Xu, Bingyang;
Wu, Na;
Wu, Jiawen

Publication type:

Article

Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 2, p. 155, doi. 10.1002/iid3.552

By:

Kaijasilta, Juha‐Pekka;
Kerola, Anne M.;
Tuompo, Riitta;
Relas, Heikki;
Loimaala, Antti;
Koivu, Hannu;
Schildt, Jukka;
Kerola, Tuomas;
Eklund, Kari;
Kauppi, Markku J.;
Nieminen, Tuomo V. M.

Publication type:

Article

The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6107217

By:

Biggioggero, Martina;
Mesina, Federica;
Favalli, Ennio Giulio

Publication type:

Article

Effusive-constrictive pericarditis as a complication of long-term treatment with adalimumab.

Published in:

2022

By:

Stipcevic, Mira;
Zekanovic, Drazen;
Patrk, Jogen;
Rudez, Igor;
Bakotic, Zoran;
Bistirlic, Marin;
Susak, Zorislav;
Buksa, Branimir;
Kosor, Stipe;
Savic, Karla;
Librenjak, Kresimir

Publication type:

Case Study

Generalized pustular psoriasis‐like widespread eruption following COVID‐19 infection in a patient with spondyloarthropathy on adalimumab.

Published in:

Experimental Dermatology, 2024, v. 33, n. 1, p. 1, doi. 10.1111/exd.14889

By:

Kamal, Kanika;
Riew, Grant J.;
Hijaz, Baraa;
Helfgott, Simon M.;
Laga, Alvaro C.;
Nambudiri, Vinod E.

Publication type:

Article

Soluble adenylyl cyclase contributes to imiquimod‐mediated inflammation and is a potential therapeutic target in psoriasis.

Published in:

Experimental Dermatology, 2023, v. 32, n. 7, p. 1051, doi. 10.1111/exd.14811

By:

You, Jaewon;
Reilly, Michael D.;
Eljalby, Mahmoud;
Bareja, Rohan;
Yusupova, Maftuna;
Vyas, Nikki S.;
Bang, Jakyung;
Ding, Wanhong;
Desman, Garrett;
Miller, Lloyd S.;
Elemento, Olivier;
Granstein, Richard D.;
Zippin, Jonathan H.

Publication type:

Article

Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa.

Published in:

Experimental Dermatology, 2022, v. 31, n. 12, p. 1872, doi. 10.1111/exd.14665

By:

Tatian, Artiene;
Bordbar, Sara;
Sarkissian, Samuel Der;
Woods, Jane A.;
Cains, Geoffrey D.;
Chong, Chun Wie;
Mariño, Eliana;
Frew, John W.

Publication type:

Article

Target molecules for future hidradenitis suppurativa treatment.

Published in:

Experimental Dermatology, 2021, v. 30, p. 8, doi. 10.1111/exd.14338

By:

Zouboulis, Christos C.;
Frew, John W.;
Giamarellos‐Bourboulis, Evangelos J.;
Jemec, Gregor B.E.;
Marmol, Veronique;
Marzano, Angelo V.;
Nikolakis, Georgios;
Sayed, Christopher J.;
Tzellos, Thrasyvoulos;
Wolk, Kerstin;
Prens, Errol P.

Publication type:

Article

Abstracts.

Published in:: 2018
Publication type:: Abstract

Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment.

Published in:

Experimental Dermatology, 2017, v. 26, n. 9, p. 804, doi. 10.1111/exd.13304

By:

Raaby, Line;
Rosada, Cecilia;
Langkilde, Ane;
Lauridsen, Kristina Lystlund;
Vinter, Hanne;
Ommen, Pernille;
Kjellerup, Rasmus Boye;
Johansen, Claus;
Iversen, Lars

Publication type:

Article

Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.

Published in:

Experimental Dermatology, 2015, v. 24, n. 1, p. 65, doi. 10.1111/exd.12575

By:

Keijsers, Romy R. M. C.;
Joosten, Irma;
Hendriks, Anke G. M.;
Koenen, Hans J. P. M;
Erp, Piet E. J;
Kerkhof, Peter C. M.

Publication type:

Article

TNF α-induced leukocyte-endothelial cell interactions show marked interindividual differences independent of the clinical response to adalimumab.

Published in:

Experimental Dermatology, 2014, v. 23, n. 2, p. 133, doi. 10.1111/exd.12283

By:

Lockmann, Anike;
Schön, Michael P.

Publication type:

Article

A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 7, p. 539, doi. 10.1111/ajd.14353

By:

Russell, Rhiannon;
Daniel, Benjamin S.

Publication type:

Article

Biologic treatment sequences in moderate‐to‐severe psoriasis.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 7, p. e178, doi. 10.1111/ajd.14350

By:

Ting, Samantha;
Lowe, Patricia;
Smith, Annika;
Fernández‐Peñas, Pablo

Publication type:

Article

Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 4, p. e111, doi. 10.1111/ajd.14266

By:

Salvia, Giorgia;
Bevilacqua, Matteo;
Manzo Margiotta, Flavia;
Michelucci, Alessandra;
Granieri, Giammarco;
Fidanzi, Cristian;
Dini, Valentina;
Romanelli, Marco;
Mazzatenta, Carlo

Publication type:

Article